1 Market Overview of Ovarian Cancer Therapeutics 1.1 Ovarian Cancer Therapeutics Market Overview 1.1.1 Ovarian Cancer Therapeutics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Ovarian Cancer Therapeutics Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Ovarian Cancer Therapeutics Market Size by Region (2015-2026) 1.4 Global Ovarian Cancer Therapeutics Historic Market Size by Region (2015-2020) 1.5 Global Ovarian Cancer Therapeutics Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) 1.6.1 North America Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) 1.6.2 Europe Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) 1.6.4 Latin America Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) 2 Ovarian Cancer Therapeutics Market Overview by Type 2.1 Global Ovarian Cancer Therapeutics Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Ovarian Cancer Therapeutics Historic Market Size by Type (2015-2020) 2.3 Global Ovarian Cancer Therapeutics Forecasted Market Size by Type (2021-2026) 2.4 PARP 2.5 PD-L1 2.6 Angiogenesis Inhibitors 3 Ovarian Cancer Therapeutics Market Overview by Application 3.1 Global Ovarian Cancer Therapeutics Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Ovarian Cancer Therapeutics Historic Market Size by Application (2015-2020) 3.3 Global Ovarian Cancer Therapeutics Forecasted Market Size by Application (2021-2026) 3.4 Hosptial 3.5 Research 4 Global Ovarian Cancer Therapeutics Competition Analysis by Players 4.1 Global Ovarian Cancer Therapeutics Market Size (Million US$) by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovarian Cancer Therapeutics as of 2019) 4.3 Date of Key Manufacturers Enter into Ovarian Cancer Therapeutics Market 4.4 Global Top Players Ovarian Cancer Therapeutics Headquarters and Area Served 4.5 Key Players Ovarian Cancer Therapeutics Product Solution and Service 4.6 Competitive Status 4.6.1 Ovarian Cancer Therapeutics Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Bristol Myers Squibb Company 5.1.1 Bristol Myers Squibb Company Profile 5.1.2 Bristol Myers Squibb Company Main Business 5.1.3 Bristol Myers Squibb Company Products, Services and Solutions 5.1.4 Bristol Myers Squibb Company Revenue (US$ Million) & (2015-2020) 5.1.5 Bristol Myers Squibb Company Recent Developments 5.2 Eli Lilly and Company 5.2.1 Eli Lilly and Company Profile 5.2.2 Eli Lilly and Company Main Business and Company’s Total Revenue 5.2.3 Eli Lilly and Company Products, Services and Solutions 5.2.4 Eli Lilly and Company Revenue (US$ Million) (2015-2020) 5.2.5 Eli Lilly and Company Recent Development and Reaction to Covid-19 5.3 GlaxoSmithKline Plc 5.5.1 GlaxoSmithKline Plc Profile 5.3.2 GlaxoSmithKline Plc Main Business 5.3.3 GlaxoSmithKline Plc Products, Services and Solutions 5.3.4 GlaxoSmithKline Plc Revenue (US$ Million) & (2015-2020) 5.3.5 Janssen Pharmaceuticals Recent Developments 5.4 Janssen Pharmaceuticals 5.4.1 Janssen Pharmaceuticals Profile 5.4.2 Janssen Pharmaceuticals Main Business 5.4.3 Janssen Pharmaceuticals Products, Services and Solutions 5.4.4 Janssen Pharmaceuticals Revenue (US$ Million) & (2015-2020) 5.4.5 Janssen Pharmaceuticals Recent Developments 5.5 Genentech Inc. 5.5.1 Genentech Inc. Profile 5.5.2 Genentech Inc. Main Business 5.5.3 Genentech Inc. Products, Services and Solutions 5.5.4 Genentech Inc. Revenue (US$ Million) & (2015-2020) 5.5.5 Genentech Inc. Recent Developments 5.6 Astra Zeneca 5.6.1 Astra Zeneca Profile 5.6.2 Astra Zeneca Main Business 5.6.3 Astra Zeneca Products, Services and Solutions 5.6.4 Astra Zeneca Revenue (US$ Million) & (2015-2020) 5.6.5 Astra Zeneca Recent Developments 5.7 Boehringer Ingelheim GmbH 5.7.1 Boehringer Ingelheim GmbH Profile 5.7.2 Boehringer Ingelheim GmbH Main Business and Company’s Total Revenue 5.7.3 Boehringer Ingelheim GmbH Products, Services and Solutions 5.7.4 Boehringer Ingelheim GmbH Revenue (US$ Million) (2015-2020) 5.7.5 Boehringer Ingelheim GmbH Recent Development and Reaction to Covid-19 5.8 Hoffmann La Roche Ltd. 5.8.1 Hoffmann La Roche Ltd. Profile 5.8.2 Hoffmann La Roche Ltd. Main Business 5.8.3 Hoffmann La Roche Ltd. Products, Services and Solutions 5.8.4 Hoffmann La Roche Ltd. Revenue (US$ Million) & (2015-2020) 5.8.5 Hoffmann La Roche Ltd. Recent Developments 6 North America 6.1 North America Ovarian Cancer Therapeutics Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Ovarian Cancer Therapeutics Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Ovarian Cancer Therapeutics Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Ovarian Cancer Therapeutics Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Ovarian Cancer Therapeutics Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Ovarian Cancer Therapeutics Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Ovarian Cancer Therapeutics Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Ovarian Cancer Therapeutics Market Size by Region (2015-2020) (US$ Million) Table 3. Global Ovarian Cancer Therapeutics Market Size Share by Region (2015-2020) Table 4. Global Ovarian Cancer Therapeutics Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Ovarian Cancer Therapeutics Forecasted Market Size Share by Region (2021-2026) Table 6. Global Ovarian Cancer Therapeutics Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Ovarian Cancer Therapeutics Market Size by Type (2015-2020) (US$ Million) Table 8. Global Ovarian Cancer Therapeutics Revenue Market Share by Type (2015-2020) Table 9. Global Ovarian Cancer Therapeutics Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Ovarian Cancer Therapeutics Revenue Market Share by Type (2021-2026) Table 11. Global Ovarian Cancer Therapeutics Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Ovarian Cancer Therapeutics Market Size by Application (2015-2020) (US$ Million) Table 13. Global Ovarian Cancer Therapeutics Revenue Market Share by Application (2015-2020) Table 14. Global Ovarian Cancer Therapeutics Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Ovarian Cancer Therapeutics Revenue Market Share by Application (2021-2026) Table 16. Global Ovarian Cancer Therapeutics Revenue (US$ Million) by Players (2015-2020) Table 17. Global Ovarian Cancer Therapeutics Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovarian Cancer Therapeutics as of 2019) Table 19. Date of Key Manufacturers Enter into Ovarian Cancer Therapeutics Market Table 20. Global Ovarian Cancer Therapeutics Top Players Headquarters and Area Served Table 21. Ovarian Cancer Therapeutics Product Solution and Service Table 22. Global Ovarian Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Bristol Myers Squibb Company Basic Information List Table 25. Bristol Myers Squibb Company Description and Business Overview Table 26. Bristol Myers Squibb Company Ovarian Cancer Therapeutics Products, Services and Solutions Table 27. Revenue (Million US$) in Ovarian Cancer Therapeutics Business of Bristol Myers Squibb Company (2015-2020) Table 28. Bristol Myers Squibb Company Recent Developments Table 29. Eli Lilly and Company Basic Information List Table 30. Eli Lilly and Company Description and Business Overview Table 31. Eli Lilly and Company Ovarian Cancer Therapeutics Products, Services and Solutions Table 32. Revenue (Million US$) in Ovarian Cancer Therapeutics Business of Eli Lilly and Company (2015-2020) Table 33. Eli Lilly and Company Recent Developments Table 34. GlaxoSmithKline Plc Basic Information List Table 35. GlaxoSmithKline Plc Description and Business Overview Table 36. GlaxoSmithKline Plc Ovarian Cancer Therapeutics Products, Services and Solutions Table 37. Revenue (Million US$) in Ovarian Cancer Therapeutics Business of GlaxoSmithKline Plc (2015-2020) Table 38. GlaxoSmithKline Plc Recent Developments Table 39. Janssen Pharmaceuticals Basic Information List Table 40. Janssen Pharmaceuticals Description and Business Overview Table 41. Janssen Pharmaceuticals Ovarian Cancer Therapeutics Products, Services and Solutions Table 42. Revenue (Million US$) in Ovarian Cancer Therapeutics Business of Janssen Pharmaceuticals (2015-2020) Table 43. Janssen Pharmaceuticals Recent Developments Table 44. Genentech Inc. Basic Information List Table 45. Genentech Inc. Description and Business Overview Table 46. Genentech Inc. Ovarian Cancer Therapeutics Products, Services and Solutions Table 47. Revenue (Million US$) in Ovarian Cancer Therapeutics Business of Genentech Inc. (2015-2020) Table 48. Genentech Inc. Recent Developments Table 49. Astra Zeneca Basic Information List Table 50. Astra Zeneca Description and Business Overview Table 51. Astra Zeneca Ovarian Cancer Therapeutics Products, Services and Solutions Table 52. Revenue (Million US$) in Ovarian Cancer Therapeutics Business of Astra Zeneca (2015-2020) Table 53. Astra Zeneca Recent Developments Table 54. Boehringer Ingelheim GmbH Basic Information List Table 55. Boehringer Ingelheim GmbH Description and Business Overview Table 56. Boehringer Ingelheim GmbH Ovarian Cancer Therapeutics Products, Services and Solutions Table 57. Revenue (Million US$) in Ovarian Cancer Therapeutics Business of Boehringer Ingelheim GmbH (2015-2020) Table 58. Boehringer Ingelheim GmbH Recent Developments Table 59. Hoffmann La Roche Ltd. Basic Information List Table 60. Hoffmann La Roche Ltd. Description and Business Overview Table 61. Hoffmann La Roche Ltd. Ovarian Cancer Therapeutics Products, Services and Solutions Table 62. Revenue (Million US$) in Ovarian Cancer Therapeutics Business of Hoffmann La Roche Ltd. (2015-2020) Table 63. Hoffmann La Roche Ltd. Recent Developments Table 64. North America Ovarian Cancer Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 65. North America Ovarian Cancer Therapeutics Market Size Share by Country (2015-2020) Table 66. Europe Ovarian Cancer Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 67. Europe Ovarian Cancer Therapeutics Market Size Share by Country (2015-2020) Table 68. Asia-Pacific Ovarian Cancer Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 69. Asia-Pacific Ovarian Cancer Therapeutics Market Size Share by Country (2015-2020) (US$ Million) Table 70. Latin America Ovarian Cancer Therapeutics Market Size by Country (2015-2020) & (US$ Million) Table 71. Latin America Ovarian Cancer Therapeutics Market Size Share by Country (2015-2020) (US$ Million) Table 72. Middle East & Africa Ovarian Cancer Therapeutics Market Size by Players (2015-2020) (US$ Million) Table 73. Middle East & Africa Ovarian Cancer Therapeutics Market Size Share by Players (2015-2020) (US$ Million) Table 74. Ovarian Cancer Therapeutics Market Trends Table 75. Ovarian Cancer Therapeutics Market Drivers Table 76. Ovarian Cancer Therapeutics Market Challenges Table 77. Ovarian Cancer Therapeutics Market Restriants Table 78. Research Programs/Design for This Report Table 79. Key Data Information from Secondary Sources Table 80. Key Data Information from Primary Sources List of Figures Figure 1. Global Ovarian Cancer Therapeutics Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global Ovarian Cancer Therapeutics Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global Ovarian Cancer Therapeutics Market Share by Regions: 2020 VS 2026 Figure 4. North America Ovarian Cancer Therapeutics Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe Ovarian Cancer Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific Ovarian Cancer Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Ovarian Cancer Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Ovarian Cancer Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Ovarian Cancer Therapeutics Market Share by Type in 2020 & 2026 Figure 10. PARP Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. PD-L1 Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Angiogenesis Inhibitors Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Global Ovarian Cancer Therapeutics Market Size Share by Application in 2020 & 2026 Figure 14. Hosptial Market Size (US$ Million) YoY Growth (2015-2026) Figure 15. Research Market Size (US$ Million) YoY Growth (2015-2026) Figure 16. Ovarian Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Top 5 and Top 10 Players Ovarian Cancer Therapeutics Market Share in 2019 Figure 18. United States Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. Canada Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Germany Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. France Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. U.K. Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Italy Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Russia Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Nordic Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Rest of Europe Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. China Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Japan Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. South Korea Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Southeast Asia Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. India Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Australia Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Rest of Asia-Pacific Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Mexico Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Brazil Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Rest of Latin America Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Turkey Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Saudi Arabia Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. UAE Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Rest of Middle East & Africa Ovarian Cancer Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Bottom-up and Top-down Approaches for This Report Figure 42. Data Triangulation

Bristol Myers Squibb Company Eli Lilly and Company GlaxoSmithKline Plc Janssen Pharmaceuticals Genentech Inc. Astra Zeneca Boehringer Ingelheim GmbH Hoffmann La Roche Ltd.